News

Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...
Shares of Quest Diagnostics Inc. DGX slid 3.78% to $164.18 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 ...
In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and ...
Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.
Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...
NeoGenomics delivered the weakest performance against analyst estimates of the whole group. The stock is down 36.6% since ...
Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...
Thrivent Financial for Lutherans decreased its stake in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 7.1% ...
With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...
Detailed price information for Quest Diagnostics Inc (DGX-N) from The Globe and Mail including charting and trades.
Generative AI is thus significantly impactful in healthcare diagnostics. We sifted through stock screeners, financial media reports, and ETFs to compile a list of 20 diagnostics and research stocks.